Balentine LLC Merck & Co., Inc. Transaction History

Balentine LLC

$2.3 Billion
Q4 2024

A detailed history of Balentine LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Balentine LLC holds 3,003 shares of MRK stock, worth $253,513. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,003

Previous 3,703 18.9%

Holding current value

$253,513

Previous $420,000 29.05%

% of portfolio

0.01%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$96.31 - $114.76 $67,417 - $80,332	-700 Reduced 18.9%	3,003 $298,000
Q3 2024 Oct 30, 2024	BUY	$111.15 - $128.97 $80,583 - $93,503	725 Added 24.35%	3,703 $420,000
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $10.7 Million - $11.5 Million	-86,563 Reduced 96.67%	2,978 $368,000
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $390,225 - $454,699	-3,446 Reduced 3.71%	89,541 $11.8 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $688,637 - $749,403	-6,874 Reduced 6.88%	92,987 $10.1 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $155,145 - $172,295	-1,507 Reduced 1.49%	99,861 $10.3 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $64,622 - $70,436	-595 Reduced 0.58%	101,368 $11.7 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $54,352 - $60,646	528 Added 0.52%	101,963 $10.8 Million
Q4 2022 Jan 31, 2023	BUY	$87.44 - $112.11 $754,782 - $967,733	8,632 Added 9.3%	101,435 $11.3 Million
Q3 2022 Oct 26, 2022	SELL	$84.53 - $94.96 $2.75 Million - $3.09 Million	-32,555 Reduced 25.97%	92,803 $7.99 Million
Q2 2022 Oct 26, 2022	BUY	$83.49 - $94.64 $5.95 Million - $6.74 Million	71,224 Added 131.57%	125,358 $11.4 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $5.95 Million - $6.74 Million	71,224 Added 131.57%	125,358 $11.4 Million
Q1 2022 Oct 26, 2022	SELL	$73.51 - $82.4 $5.24 Million - $5.87 Million	-71,224 Reduced 56.82%	54,134 $4.44 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $2.23 Million - $2.5 Million	30,364 Added 127.74%	54,134 $4.44 Million
Q4 2021 Oct 26, 2022	SELL	$72.28 - $90.54 $7.37 Million - $9.23 Million	-101,938 Reduced 81.32%	23,420 $1.8 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $411,417 - $515,353	5,692 Added 31.49%	23,770 $1.82 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $602,255 - $662,329	8,402 Added 86.83%	18,078 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $247,280 - $273,517	3,517 Added 57.1%	9,676 $753,000
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $42,211 - $49,720	-613 Reduced 9.05%	6,159 $475,000
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $68,396 - $75,906	-953 Reduced 12.34%	6,772 $554,000
Q3 2020 Nov 02, 2020	BUY	$73.18 - $82.95 $257,886 - $292,315	3,524 Added 83.88%	7,725 $641,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $91,968 - $104,649	1,306 Added 45.11%	4,201 $325,000
Q1 2020 May 18, 2020	SELL	$63.36 - $87.82 $316 - $439	-5 Reduced 0.17%	2,895 $223,000
Q4 2019 Sep 02, 2020	BUY	$77.58 - $87.54 $152,599 - $172,191	1,967 Added 210.83%	2,900 $264,000
Q3 2019 Nov 15, 2019	BUY	$76.08 - $82.93 $26,171 - $28,527	344 Added 58.4%	933 $79,000
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $19,345 - $22,600	277 Added 88.78%	589 $49,000
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $5,249 - $6,173	91 Added 41.18%	312 $22,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $11,233 - $13,198	221 New	221 $13,000
Q1 2018 May 16, 2018	SELL	$50.96 - $59.23 $114,558 - $133,149	-2,248 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $3,768 - $4,499	-73 Reduced 3.15%	2,248 $126,000
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $136,173 - $146,524	2,321	2,321 $149,000

Others Institutions Holding MRK

# of Institutions

3,914

Shares Held

1.94B

Call Options Held

15.9M

Put Options Held

14M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $214B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account